Literature DB >> 23966500

Comparative evaluation of BD Phoenix and vitek 2 systems for species identification of common and uncommon pathogenic yeasts.

Brunella Posteraro1, Alberto Ruggeri, Elena De Carolis, Riccardo Torelli, Antonietta Vella, Flavio De Maio, Walter Ricciardi, Patrizia Posteraro, Maurizio Sanguinetti.   

Abstract

The BD Phoenix system was evaluated for species-level identification of yeasts (250 clinical isolates) and compared with the Vitek 2 system, using ribosomal internal transcribed spacer (ITS) sequence analysis as the gold standard. Considering only the species included in each system's database, 96.3% (236/245) and 91.4% (224/245) of the isolates were correctly identified by BD Phoenix and Vitek 2, respectively.

Entities:  

Mesh：

Year:  2013        PMID： 23966500      PMCID： PMC3889777          DOI： 10.1128/JCM.01581-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  28 in total

1.  Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.

Authors:  Emilia Cantón; Javier Pemán; Guillermo Quindós; Elena Eraso; Ilargi Miranda-Zapico; María Álvarez; Paloma Merino; Isolina Campos-Herrero; Francesc Marco; Elia Gomez G de la Pedrosa; Genoveva Yagüe; Remedios Guna; Carmen Rubio; Consuelo Miranda; Carmen Pazos; David Velasco
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Current issues in the clinical management of invasive candida infections--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009.

Authors:  M Karthaus; M J G T Rüping; O A Cornely; A Steinbach; A H Groll; C Lass-Flörl; H Ostermann; M Ruhnke; J J Vehreschild
Journal:  Mycoses       Date:  2011-05-10       Impact factor: 4.377

Review 3.  MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyond.

Authors:  Brunella Posteraro; Elena De Carolis; Antonietta Vella; Maurizio Sanguinetti
Journal:  Expert Rev Proteomics       Date:  2013-04       Impact factor: 3.940

4.  Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.

Authors:  Ilargi Miranda-Zapico; Elena Eraso; José Luis Hernández-Almaraz; Leyre Mónica López-Soria; Alfonso Javier Carrillo-Muñoz; Juan Manuel Hernández-Molina; Guillermo Quindós
Journal:  J Antimicrob Chemother       Date:  2011-07-26       Impact factor: 5.790

Review 5.  Uncommon yeast infections in hematological patients: from diagnosis to treatment.

Authors:  Morena Caira; Enrico Maria Trecarichi; Mario Tumbarello; Giuseppe Leone; Livio Pagano
Journal:  Expert Rev Anti Infect Ther       Date:  2011-11       Impact factor: 5.091

Review 6.  Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review.

Authors:  Matthew E Falagas; Nikos Roussos; Konstantinos Z Vardakas
Journal:  Int J Infect Dis       Date:  2010-08-24       Impact factor: 3.623

7.  Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).

Authors:  Olivier Leroy; Jean-Pierre Gangneux; Philippe Montravers; Jean-Paul Mira; François Gouin; Jean-Pierre Sollet; Jean Carlet; Jacques Reynes; Michel Rosenheim; Bernard Regnier; Olivier Lortholary
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

8.  Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs.

Authors:  Mariana Castanheira; Leah N Woosley; Daniel J Diekema; Ronald N Jones; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

Review 9.  Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis.

Authors:  Benoît P Guery; Maiken C Arendrup; Georg Auzinger; Elie Azoulay; Márcio Borges Sá; Elizabeth M Johnson; Eckhard Müller; Christian Putensen; Coleman Rotstein; Gabriele Sganga; Mario Venditti; Rafael Zaragoza Crespo; Bart Jan Kullberg
Journal:  Intensive Care Med       Date:  2008-10-30       Impact factor: 17.440

10.  Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature.

Authors:  Shawn R Lockhart; Shawn A Messer; Michael Gherna; Justin A Bishop; William G Merz; Michael A Pfaller; Daniel J Diekema
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948
View more
  7 in total

Review 1.  Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy.

Authors:  Brunella Posteraro; Ljupcho Efremov; Emanuele Leoncini; Rosarita Amore; Patrizia Posteraro; Walter Ricciardi; Maurizio Sanguinetti
Journal:  J Clin Microbiol       Date:  2015-05-20       Impact factor: 5.948

2.  Comparison and optimization of two MALDI-TOF MS platforms for the identification of medically relevant yeast species.

Authors:  M A Pence; E McElvania TeKippe; M A Wallace; C-A D Burnham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-07       Impact factor: 3.267

3.  Misidentification of a Rare Species, Cryptococcus laurentii, by Commonly Used Commercial Biochemical Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Systems: Challenges for Clinical Mycology Laboratories.

Authors:  Meng Xiao; Xin Fan; Xin-Xin Chen; He Wang; Li Zhang; Zhi-Peng Xu; Timothy Kudinha; Fanrong Kong; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2015-11-11       Impact factor: 5.948

4.  Comparison of the accuracy of two conventional phenotypic methods and two MALDI-TOF MS systems with that of DNA sequencing analysis for correctly identifying clinically encountered yeasts.

Authors:  Qiao-Ting Chao; Tai-Fen Lee; Shih-Hua Teng; Li-Yun Peng; Ping-Hung Chen; Lee-Jene Teng; Po-Ren Hsueh
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

5.  Comparison between MALDI-TOF MS and MicroScan in the identification of emerging and multidrug resistant yeasts in a fourth-level hospital in Bogotá, Colombia.

Authors:  Andrés Ceballos-Garzón; Gloria Cortes; Florent Morio; Edna L Zamora-Cruz; Melva Y Linares; Beatriz E Ariza; Sandra L Valderrama; Javier R Garzón; Carlos A Alvarez-Moreno; Patrice Le Pape; Claudia M Parra-Giraldo
Journal:  BMC Microbiol       Date:  2019-05-23       Impact factor: 3.605

6.  Candida glabrata Empyema Thoracis-A Post-COVID-19 Complication.

Authors:  Neeraja Swaminathan; Katherine Anderson; Joshua D Nosanchuk; Matthew J Akiyama
Journal:  J Fungi (Basel)       Date:  2022-08-30

7.  Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification.

Authors:  Michelle L Grant; Shobha Parajuli; Raquel Deleon-Gonsalves; Raghava Potula; Allan L Truant
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-04-14       Impact factor: 2.471
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.